Contraceptive Technology Update – February 1, 2014
February 1, 2014
View Issues
-
FDA eyes LNG ECP label change in light of research on weight impact
Labeling for the European levonorgestrel (LNG) emergency contraceptive pill NorLevo has been revised due to data indicating lower drug efficacy in women weighing 165 pounds and above. This move has led U.S. regulators to assess data on similar products. -
Cervical cancer screens overused in some groups
A review of 10 years of national data indicates that clinicians have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women: those who have undergone hysterectomies and those older than age 65 with no cervical cancer history. -
Condom technology is now focus of research
The Bill & Melinda Gates Foundation has just released funding to support 11 projects that aim to improve uptake and regular use of male and female condoms by developing new designs that significantly preserve or enhance pleasure and simplify use. -
Use key instructions for correct condom use
-
Multipurpose methods show research advances
Strides are being made in development of multipurpose prevention technologies, defined as a single product or strategy configured for at least two sexual and reproductive health prevention indications: unintended pregnancy, HIV, and other sexually transmitted infections. -
How to address deaths from ovarian cancer
A woman in her late 40s dies less than a year after ovarian cancer is diagnosed. She has three daughters ranging from 15 to 25 years of age. How can ovarian cancer be prevented in these three young women? How can ovarian cancer be prevented during the lifetime of ANY woman, whether or not she has a family history of ovarian cancer?
-
How you can remove HPV vaccination barriers